ViferaXS GmbH
PrivateCompany Overview
ViferaXS GmbH operates in Healthcare & Life Sciences and is based in Tübingen. It was founded in 2022.
ViferaXS GmbH is a biotechnology company that develops peptide-based T cell activators for the treatment of cancer and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Precision Medicine
Business Model
B2B
Customer Profile
Revenue Share, Services & Consulting
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
ViferaXS GmbH Comparables
Compare ViferaXS GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| BayVax Biotech Limited | 78% | |
| ImmuneSpec | 76% | |
| Gritstone bio | 73% |
For institutional investors. Book with your work email.
ViferaXS GmbH Funding Rounds
Historical fundraising activity
Recent news
Latest coverage and updates
- is_developingSep 23, 2026
ViferaXS GmbH is developing cancer immunotherapies based on its proprietary T Cell Activator technology, which activates cytotoxic T cells against naturally presented tumor antigens across hematologic malignancies and solid tumors.
- receives_financingSep 23, 2026
ViferaXS GmbH closed a $13.8M Series A financing round, including grant funding, led by SPRIND and Huma with participation from private investors, to fund a Phase II chronic lymphocytic leukemia trial and support its acute myeloid leukemia and fibrolamellar carcinoma programs in Germany on Sep 23rd '26.
For institutional investors. Book with your work email.
ViferaXS GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about ViferaXS GmbH's valuation, stock price, and market status.
Is ViferaXS GmbH a public or private company?
ViferaXS GmbH is a private company.
What is the current stock price of ViferaXS GmbH?
ViferaXS GmbH is a private company, so its shares have no public market price. Caplight tracks ViferaXS GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is ViferaXS GmbH worth (valuation)?
Valuation information for ViferaXS GmbH is not publicly available.
Can I buy ViferaXS GmbH stock?
ViferaXS GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was ViferaXS GmbH's last funding round?
Funding round information for ViferaXS GmbH is not publicly available.
Who are the main investors in ViferaXS GmbH?
Investor information for ViferaXS GmbH is not publicly disclosed.
Will ViferaXS GmbH IPO soon?
No public IPO plans have been announced for ViferaXS GmbH.
How can I track ViferaXS GmbH secondary market activity?
Caplight tracks bids, offers, and trades in ViferaXS GmbH's shares on secondary markets.